Tag: Vaccines
Moderna Vaccine Shows 94.5 Percent Effectiveness Against COVID-19
Company expects to have about 20 million doses of the vaccine ready to ship in the U.S. by the end of the year
Measles Cases Reach Highest Number in 23 Years
After steady decline in 2010 to 2016, measles cases increased in all WHO regions from 2017 to 2019; deaths increased 50 percent
AstraZeneca Hopes to Have COVID-19 Vaccine Ready by Year’s End
To ensure the vaccine has the longest possible shelf-life, company is not producing injectable vials of the vaccine yet
HPV Vaccine Generally Well Tolerated in Males
Disproportionate reports found for some adverse events, including syncope, with reporting odds ratio of 2.85
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
U.S. Food and Drug Administration authorized the restart after reviewing all safety data
CDC: Vaccination Coverage Generally High by Age 24 Months
Coverage with at least two doses of flu vaccine higher for children born 2016 to 2017 versus 2014 to 2015
CDC Plans Cellphone COVID-19 Vaccine Tracking System
Health checks will be done by text messages and email every day during the first week after vaccination
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
Polls show Americans getting more skeptical about a vaccine, worry that approval process is being rushed
U.S. COVID-19 Vaccine Trial Enrolls 30,000
Moderna says it is on track to apply for FDA approval to market the vaccine in early December
Vaccine Attributes Influence Readiness to Accept COVID-19 Shot
Political considerations also influence preference for choosing a hypothetical COVID-19 vaccine
